Shopping Cart 0
Cart Subtotal
USD 0

Green Cross Cell Corp (031390) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Green Cross Cell Corp (031390)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Green Cross Cell Corp (Green Cross Cell), a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of cord blood Cord blood that contains stem cells, which can be used to treat various diseases such as pediatric cancer, leukemia, stroke, diabetes, and liver diseases, among others. Green Cross Cell offers contract services ranging from manufacturing of the biopharmaceuticals, processing, cell storage, and consulting, to the product delivery. The company also carries out research programs targeted at the treatment of leukemia, pancreatic cancer, ovarian cancer, acquired immunodeficiency syndrome (AIDS) and glioblastoma. Green Cross Cell is headquartered in Seoul, South Korea.

Green Cross Cell Corp Key Recent Developments

Sep 14,2017: Green Cross Cell, Maryland agree to expand the cooperation between the biohealth and life science sectors

Aug 30,2017: Green Cross Cell: Acquisition of INNO-BIZ certification

Apr 14,2017: Green Cross Cell, the launch of a colorectal cancer clinical trial

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Green Cross Cell Corp-Key Facts 5

Green Cross Cell Corp-Key Employees 6

Green Cross Cell Corp-Key Operational Employees 7

Green Cross Cell Corp-Major Products and Services 8

Green Cross Cell Corp-History 9

Green Cross Cell Corp-Company Statement 10

Green Cross Cell Corp-Locations And Subsidiaries 11

Head Office 11

Section 2-Company Analysis 12

Company Overview 12

Green Cross Cell Corp-Business Description 13

R&D Overview 13

Green Cross Cell Corp-Corporate Strategy 14

Green Cross Cell Corp-SWOT Analysis 15

SWOT Analysis-Overview 15

Green Cross Cell Corp-Strengths 15

Green Cross Cell Corp-Weaknesses 16

Green Cross Cell Corp-Opportunities 17

Green Cross Cell Corp-Threats 18

Green Cross Cell Corp-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

Green Cross Cell Corp, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

Sep 14, 2017: Green Cross Cell, Maryland agree to expand the cooperation between the biohealth and life science sectors 30

Aug 30, 2017: Green Cross Cell: Acquisition of INNO-BIZ certification 31

Apr 14, 2017: Green Cross Cell, the launch of a colorectal cancer clinical trial 32

Section 6-Appendix 33

Methodology 33

Ratio Definitions 33

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Green Cross Cell Corp, Performance Chart (2013-2017) 24

Green Cross Cell Corp, Ratio Charts 26

Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28


List Of Table

List of Tables

Green Cross Cell Corp, Key Facts 5

Green Cross Cell Corp, Key Employees 6

Green Cross Cell Corp, Key Operational Employees 7

Green Cross Cell Corp, Major Products and Services 8

Green Cross Cell Corp, History 9

Green Cross Cell Corp, Key Competitors 19

Green Cross Cell Corp, Ratios based on current share price 20

Green Cross Cell Corp, Annual Ratios 21

Green Cross Cell Corp, Annual Ratios (Cont...1) 22

Green Cross Cell Corp, Annual Ratios (Cont...2) 23

Green Cross Cell Corp, Interim Ratios 25

Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

Green Cross Cell Corp, Recent Deals Summary 29

Currency Codes 33

Capital Market Ratios 33

Equity Ratios 34

Profitability Ratios 34

Cost Ratios 35

Liquidity Ratios 35

Leverage Ratios 36

Efficiency Ratios 36

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Green Cross Cell Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

SeouLin Bioscience Co Ltd

Pharmicell Co Ltd

NanoEnTek Inc.

MediPost Co Ltd

Genexine Inc

Bioneer Corp